On October 30, 2025, Elevation Capital Advisory executed what can only be described as a full retreat from ONEQ. The filing with the SEC revealed a complete liquidation of their position, leaving the fund with zero shares. For context, ONEQ had previously been 3.57% of their AUM. Now? A bold, if slightly panicked, zero. One wonders if they’re rebalancing or simply reacting to the market’s latest performance review.
The acquisition, equivalent to a 0.98% crescendo in their 13F AUM symphony, now positions Futu as the 1.94% whisper in their portfolio’s ear – a supporting role, not the leading man. The fund’s current holding of 47,988 shares, valued at $8.35 million, might seem modest to the vulgar eye, but to the connoisseur it speaks volumes of calculated restraint.
Picture this: Vantage had Floor & Decor in their portfolio at $90 a share. Now they’re selling it at $76. That’s like buying a brand-new Tesla and then trying to resell it at a yard sale. The fund’s Q3 2025 filing reveals they reduced their position from 1.28% of AUM to zero. For context, their top holdings now include United Health Group ($107.57M), Alphabet ($106.25M), and Nvidia ($62.01M). If I were FND, I’d be feeling the chill of a post-Thanksgiving clearance sale.
VOOG, the restless prospector, sifts only for growth-the shimmering nuggets of companies racing ahead like jackrabbits. VOO, the steady farmer, casts its net wide, harvesting both growth’s wild wheat and value’s rooted potatoes. Let us walk their trails.
The fund now holds 1,610,332 shares, valued at $157.23 million, making Axcelis its largest holding at 5.1% of AUM.
According to the 14th of October’s SEC filing-a document as eagerly anticipated in certain circles as the latest Agatha Christie-this reduction saw the firm’s holdings shrink to 21,861 shares, valued at $9.78 million. Picture, if you will, a gentleman reluctantly surrendering his last truffle at a dinner party: the sale represented 30% of their previous position, though one suspects the fund’s appetite remains intact. [em]The stock, you see, had been in something of a sulk[/em], down 10.6% year-on-year, sulking like a debutante excluded from the season’s premier ball.
An SEC filing from October 14, 2025, notes the reduction of AHB’s stake in the retail giant. The shares, sold at an average quarterly price, left a placeholder in the firm’s capital allocation-a gesture as quiet as a shuffled deck of cards after a long night’s game.
The filing reveals that Investment Planning Advisors, Inc. didn’t just dip their toes in the QQQM pool-they cannonballed. With 72,104 shares acquired at an average quarterly price of $247.00, the trade now accounts for 5.6% of their 13F reportable AUM. Imagine if your portfolio were a dinner party: QQQM would be the guest who arrives early, stays late, and steals the spotlight. Plot twist: They’re also the one who spills wine on the carpet.
According to the aforementioned filing, Palisades, in a gesture of prudence, liquidated its stake in Innodata during Q3 2025. The sum realized, though considerable, was calculated based on the average closing price for the quarter. Post-sale, the fund retained a modest holding of 7,708 shares, valued at $594,056 as of September 30, 2025-a far cry from its former prominence.
This wasn’t a sale. It was a dissection. The Swiss fund carved its stake down to 305,333 shares, a skeleton crew of what once was 1.6% of their 13F portfolio. Now that’s 0.2% lingering like a bad debt.